Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: Frankfurt
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

Integra LifeSciences Holdings Corp

+ Add to Watchlist

IL3:GR

28.020 EUR 0.355 1.28%

As of 02:05:24 ET on 05/17/2013.

Company Profile for Integra LifeSciences Holdings Corp (IL3)

Integra LifeSciences Holdings develops, manufactures, and markets medical devices, implants, and biomaterials. The Company's products are primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics, and other surgical applications.

Contact Information

Integra LifeSciences Holdings Corp

311 Enterprise Drive
Plainsboro, NJ 08536
United States
Phone: 1-609-275-0500
Fax: 1-609-275-5363

Key Executives for Integra LifeSciences Holdings Corp (IL3)

Peter J ArduiniPresident/CEOPadma ThiruvengadamVP/Chief Human Resources Ofcr
Robert D PaltridgeVP/Pres:ExtremityBrian LarkinVP/Pres:Global Spine
Dan ReuversVP/Pres:InstrumentsDeborah A Leonetti "Debbie"VP/Pres:International
Robert T Davis JrVP/Pres:NeurosurgeryRichard D GorelickVP/Secy/General Counsel
Jerry E CorbinVP/ControllerJohn B Henneman IIIVP:Finance/CFO
Joseph VinhaisVP:Global Quality AssuranceJudith E O'GradyVP:Regulatory Affairs
John MooradianVP:Global Ops & Supply Chain

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil